Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Pharma
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
A new appraisal by the U.K.'s cost-effectiveness gatekeeper threatens to spark another dispute over the cost of Vertex's cystic fibrosis drugs.
Fraiser Kansteiner
Nov 6, 2023 2:42pm
'The Top Line': 2022's top M&A deals and 2023's potential
Feb 10, 2023 6:00am
Vertex's Trikafta at center of new pricing controversy
Feb 7, 2023 10:59am
Don't pigeonhole Vertex as a rare disease company, execs say
May 6, 2022 7:55am
Vertex's CEO scored a major pay bump in 2021
Apr 8, 2022 11:10am
Is the cost of Vertex's Trikafta hampering CF treatment?
Feb 14, 2022 11:46am